CareCloud (NASDAQ:CCLD – Get Free Report) and HeartSciences (NASDAQ:HSCS – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, profitability, earnings, institutional ownership and valuation.
Volatility & Risk
CareCloud has a beta of 1.52, meaning that its stock price is 52% more volatile than the S&P 500. Comparatively, HeartSciences has a beta of 1.78, meaning that its stock price is 78% more volatile than the S&P 500.
Profitability
This table compares CareCloud and HeartSciences’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| CareCloud | 7.87% | 24.05% | 16.38% |
| HeartSciences | N/A | -333.50% | -140.18% |
Earnings and Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| CareCloud | $120.50 million | 0.78 | $10.80 million | $0.11 | 20.18 |
| HeartSciences | N/A | N/A | -$8.77 million | ($4.94) | -0.56 |
CareCloud has higher revenue and earnings than HeartSciences. HeartSciences is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.
Insider and Institutional Ownership
10.2% of CareCloud shares are owned by institutional investors. Comparatively, 17.2% of HeartSciences shares are owned by institutional investors. 14.8% of CareCloud shares are owned by company insiders. Comparatively, 4.9% of HeartSciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Analyst Recommendations
This is a summary of recent ratings and target prices for CareCloud and HeartSciences, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| CareCloud | 0 | 2 | 1 | 0 | 2.33 |
| HeartSciences | 1 | 0 | 1 | 0 | 2.00 |
CareCloud currently has a consensus price target of $3.25, indicating a potential upside of 46.40%. HeartSciences has a consensus price target of $8.00, indicating a potential upside of 186.74%. Given HeartSciences’ higher possible upside, analysts clearly believe HeartSciences is more favorable than CareCloud.
Summary
CareCloud beats HeartSciences on 9 of the 12 factors compared between the two stocks.
About CareCloud
CareCloud, Inc., a healthcare information technology (IT) company, provides a suite of cloud-based solutions and related business services to healthcare providers and hospitals primarily in the United States. It operates in two segments, Healthcare IT and Medical Practice Management. The company's portfolio of proprietary software and business services includes technology-enabled business solutions; cloud-based software; digital health services; healthcare IT professional services and staffing; and medical practice management services. Its technology-enabled business solutions comprise revenue cycle management services, healthcare claims clearinghouse, and medical coding and credentialing services; electronic health records, practice management software and related capabilities, patient experience management solutions, business intelligence and healthcare analytics platforms, and customized applications, interfaces, and various other technology solutions, as well as artificial intelligence, such as CareCloud cirrusAI, AI-powered clinical decision support, AI-powered virtual support assistant, AI-driven appeals, and CareCloud cirrusAI. In addition, the company provides chronic care management, remote patient monitoring, and telemedicine solutions; and professional and consulting services, workforce augmentation and on-demand staffing, and strategic advisory services. Further, it offers medical practice management services to medical practices comprising appropriate facilities, equipment, supplies, support services, nurses, and administrative support staff, as well as management, bill-paying, and financial advisory services. It serves physicians, nurses, nurse practitioners, physician assistants, and other clinicians that render bills for their services. The company was formerly known as MTBC, Inc. and changed its name to CareCloud, Inc. in March 2021. CareCloud, Inc. was founded in 1999 and is headquartered in Somerset, New Jersey.
About HeartSciences
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.
Receive News & Ratings for CareCloud Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CareCloud and related companies with MarketBeat.com's FREE daily email newsletter.
